Identification of new biomarker for Alzheimer's could set stage for clinical laboratory test to identify and diagnosis the disease in its early stages
from DARK Daily
Researchers in Mexico developed a skin test that could lead to the early diagnosis of Alzheimer's disease and pave the way for new therapies to treat a disease ranked as the sixth leading cause of death in the United States. For clinical pathologists and medical laboratories, a testing breakthrough would be significant since the Alzheimer's Association predicts that the number of Americans 65 and older with Alzheimer's disease will reach 7.1 million by 2025, a 40 percent increase from today.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063